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Abstract
Breast cancer with cartilaginous and/or osseous metaplasia is a type of metaplastic carcinomas
and is a rare disease. We report the case of a 49 year-old female who underwent right mastectomy
for a large breast tumor. Histological examinations revealed a mixed tumor with both stromal and
epithelial elements;the stroma showed poor differentiated spindle-shape and multiform cells with
a massive osseous matrix, and atypical epithelial cells, which mainly existed on the surface of
the cysts, showed nucleic atypia. The tumor was diagnosed as a malignant phyllodes tumor with
osteosarcomatous differentiation;it was not identified as a metaplastic carcinoma because of the
lack of proof of a cancerous component. Two years after a mastectomy, swelling of the axillary
lymph nodes was found and a biopsy was performed. Histological findings for the lymph node
indicated a metastasis of the invasive ductal carcinoma. The primary tumor was re-examined and
was considered to be the origin of the lymph nodal metastasis. Lymph nodal metastasis of cancer
proved that the primary tumor had cancerous potential, and the pathological diagnosis was altered
to a breast cancer with cartilaginous and/or osseous metaplasia.
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Breast cancer with cartilaginous and/or osseous metaplasia is a type of metaplastic carcinomas and is 
a rare disease.  We report the case of a 49 year-old female who underwent right mastectomy for a 
large breast tumor.  Histological examinations revealed a mixed tumor with both stromal and epithe-
lial elements; the stroma showed poor diﬀerentiated spindle-shape and multiform cells with a massive 
osseous matrix,  and atypical epithelial cells,  which mainly existed on the surface of the cysts,  showed 
nucleic atypia.  The tumor was diagnosed as a malignant phyllodes tumor with osteosarcomatous 
diﬀerentiation; it was not identiﬁed as a metaplastic carcinoma because of the lack of proof of a 
cancerous component.  Two years after a mastectomy,  swelling of the axillary lymph nodes was found 
and a biopsy was performed.  Histological ﬁndings for the lymph node indicated a metastasis of the 
invasive ductal carcinoma.  The primary tumor was re-examined and was considered to be the origin 
of the lymph nodal metastasis.  Lymph nodal metastasis of cancer proved that the primary tumor had 
cancerous potential,  and the pathological diagnosis was altered to a breast cancer with cartilaginous 
and/or osseous metaplasia.
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reast cancer with cartilaginous and/or osseous 
metaplasia is a special types of invasive breast 
cancer and has been reported to occur in only 0.003-
0.12ｵ of breast cancer cases [1,  2].  This breast 
cancer is characterized as a cartilaginous or osseous 
metaplasia,  or both,  in breast cancer tissue,  and as a 
transitional zone between carcinoma and sarcoma-like 
metaplastic lesions.  Based on these criteria of diagno-
sis,  histological diagnosis is diﬃcult in some cases.  
We report herein a case of metaplastic carcinoma that 
had been diagnosed as a malignant phyllodes tumor 
because a sarcoma-like metaplastic lesion was domi-
nant and epithelial malignancy could not conﬁrmed in 
the primary tumor.  The diagnosis of metaplastic car-
cinoma was ﬁnally made after identifying the presence 
of lymph nodal metastasis.
Case Report
　 A 49 year-old female patient had noticed a right 
breast tumor but did not consult a physician for 9 
months.  On a regular visit to our hospital for primary 
biliary cirrhosis and diabetes mellitus,  which had been 
treated for the last 10 years,  a physician noticed the 
breast tumor and consulted a general surgeon.  The 
tumor occupied the entire right breast with skin 
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involvement,  redness,  and ulceration and was ﬁxed to 
the anterior chest wall.  The tumor measured 20×16
×13cm,  but no right axillary or supra-clavicular 
lymph nodes were palpable.  Mammography and mag-
netic resonance imaging revealed a huge heteroge-
neous mass with multiple cystic regions and septa 
(Fig.  1).  A high intensity T2-weighted image indi-
cated a pooling of blood or ﬂuid inside of the cysts.  
Invasion to the skin and major pectoral muscle was 
shown,  but no axillary lymph nodal swelling was 
observed.  Other imaging modalities revealed no evi-
dence of liver,  lung,  or bone metastases.  Fine-needle 
aspiration biopsy did not conﬁrm the diagnosis.  After 
hospitalized treatment for primary biliary cirrhosis,  
surgical treatment was undertaken.  Though ascites 
had diminished and the prothrombin time was normal-
ized,  the patient continued to suﬀer from jaundice and 
hypoalbuminemia; total bilirubin and albumin levels of 
5.7mg/dl and 2.6g/dl,  respectively,  persisted at the 
time of the surgery.  A simple mastectomy with a 
major pectoral muscle resection was performed but 
axillary lymphadenectomy was not undertaken,  
because of the patientʼs poor general condition.
　 The tumor showed a honeycomb structure,  and 
cystic lesions contained hemorrhage and serous ﬂuid 
(Fig.  2).  Microscopic examination revealed as a 
mixed tumor with both stromal and epithelial elements.  
The stroma showed a high cellularity with poor dif-
ferentiated spindle-shape and multiform cells and 
osteosarcoma like appearance,  and osteoblast-like 
cells with a massive osseous matrix were also shown 
in some areas (Fig.  3A-D).  Cuboid and polygonal 
epithelial cells were found mainly on the surface of the 
cystic lesions (Fig.  3E) and showed hyperplasia and 
nucleic atypia.  But cancer cell nests with invasion or 
inﬁltration to the stroma or massive vessel invasions 
were not found.  The possibility of a metaplastic 
breast cancer versus malignant phyllodes tumor was 
suggested and a diagnosis of a malignant phyllodes 
tumor with osteosarcomatous diﬀerentiation was made 
at this time,  because cancerous changes in the primary 
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Fig. 1　 A,  Mammography demonstrated a huge tumor in the right breast.  Coarse calciﬁcation was not observed; B,  T1-weighted image 
of MRI demonstrated a low-intensity and heterogeneous tumor in the right breast; C,  The high-intensity of the T2-weighted image implied 
a cystic lesion with pooling of blood or body ﬂuid.
Fig. 2　 The macroscopic view of the primary tumor showed a 
honeycomb structure and cystic lesions.
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Fig. 3　 Histological ﬁndings of the primary tumor.  A, B: H&E staining showed a mixed tumor with both stromal and epithelial elements 
(bar: A,  100µm,  B,  20µm); C,  Azan staining showed a massive osseous matrix (bar: 40µm); D,  Arrows indicate osteoclast-like giant 
cells (bar: 20µm); E,  The epithelial cells on the surface of the cystic lesion showed nucleic atypia (bar: 30µm); F,  Arrows indicate the 
cluster of epithelial cells in the lymphatic vessels (bar: 10µm); G,  34βE12 was positive in epithelial cells, but not in the stromal area 
(bar: 20µm) (anti-34βE12 was purchased from Dako,  Glostrup,  Denmark); H,  CD34 was negative in both the epithelial and stromal 
areas (bar: 20µm) (anti-CD34 class II antibody was purchased from Dako).
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tumor had not been clariﬁed.  This tumor was estrogen 
receptor-negative and progesterone receptor-negative.
　 During the 21st month following the surgery,  com-
puted tomography revealed right axillary lymph nodal 
swelling.  The lymph nodes were gradually enlarged 
and biopsied for the pathological examination 28- 
months after the previous surgery.  One out of 8 
resected lymph nodes showed metastasis of ductal 
carcinoma (Fig.  4A).  Immunohistochemistry revealed 
that these cancer cells had cytoplasmic positive 
expression of gross cystic disease ﬂuid protein 15 
(GCDFP15)/prolactin-inducible protein (PIP),  char-
acterized by apocrine cells (Fig.  4B).  Epithelial cells 
of the primary breast tumor also expressed GCDFP15 
in their cytoplasm,  which is consistent with cancer 
cells of the axillary lymph node.  GCDFP15 is a 
marker of apocrine epithelium and showed a positive 
test in malignancies such as a breast carcinoma with 
apocrine feature or Pagetʼs disease.  In the present 
case,  the primary breast tumor was considered to be 
the origin of the lymph nodal metastasis,  which proved 
that the epithelial component of the primary tumor had 
malignant characteristics.  Thus the pathological diag-
nosis of primary breast tumor was altered to cancer 
with cartilaginous and/or osseous metaplasia and 
lymph nodal metastasis.  Re-examination of the pri-
mary tumor was carried out,  and a cluster of epithe-
lial cells in lymphatic vessels that suggested lymphatic 
invasion was found (Fig.  3F),  but cancer cell nests 
with invasive proliferation were not conﬁrmed.  
According to Dunneʼs report [3],  immunohistochemi-
cal examination with 34βE12 and CD34 was also 
performed.  Though the epithelial component was 
positive for 34βE12,  either 34βE12 or CD34 was 
negative in the stromal area (Fig.  3G,  H).  Positive 
staining of cytokeratins in the stromal area is consid-
ered to support a diagnosis of metaplastic carcinoma,  
but such positive staining did not occur in this case.  
Adjuvant chemotherapy was not undertaken because of 
liver dysfunction.  No liver tumor or other malignan-
cies were conﬁrmed throughout the observation 
period.  Though no recurrence was observed over a 
12-month follow-up period,  the patient died of liver 
failure.
Discussion
　 Breast cancer with cartilaginous and/or osseous 
metaplasia is a special type of invasive breast cancer.  
The clinicopathological features of this cancer have 
been reported to be a comparatively large tumor size 
with rapid enlargement,  a lack of speciﬁc ﬁndings on 
radiographic examinations,  an occasional cystic pat-
tern,  and the presence of necrotic or hemorrhagic 
tissues [4,  5].  In addition,  metastasis to axillary 
lymph nodes is rarely observed and occurs at a rate 
comparable to common breast cancers.  Cartilaginous 
or osseous metaplasia is observed in the breast cancer 
tissue derived from glandular epithelium,  and a tran-
sitional zone exists between carcinoma and sarcoma-
like metaplastic lesions.  It has been reported that 
these cancers show cartilaginous metaplasia alone in 
51ｵ of cases,  both cartilaginous and osseous meta-
plasia in 42ｵ of cases,  and osseous metaplasia alone 
in 7ｵ of cases [6].
　 The diﬀerential diagnosis is important with this 
cancer because diseases of the mammary gland with 
cartilaginous and/or osseous metaplasia include phyl-
lodes tumor,  primary sarcoma,  and mixed ﬁbroma-
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Fig. 4　 Histological ﬁndings of the axillary lymph node.  A,  
Histology of the lymph node showed metastasis of ductal carci-
noma (bar: 30µm); B,  Immunohistochemistry revealed that cancer 
cells had positive expression of GCDFP15/PIP (anti-GCDFP15 
was purchased from Kyodo Byori,  Kobe,  Japan) (bar: 30µm).
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toses [7].  In our case,  the primary pathological 
diagnosis was malignant phyllodes tumor with osteo-
sarcomatous diﬀerentiation because the presence of 
cancerous components such as invasive proliferation or 
metastasis at the time of the ﬁrst surgery could not be 
conﬁrmed.  We ﬁnally made a diagnosis of metaplastic 
carcinoma,  however,  because lymph nodal metastasis 
was shown later; immunohistochemical examination of 
the epithelial components of the primary breast tumor 
was consistent with metastatic carcinomas of the 
lymph node.  Though reexamination of the primary 
tumor has carried out after the recurrence,  it was 
diﬃcult to conﬁrm the presence of cancerous compo-
nents in the primary tumor histologically.  Immuno-
histochemical markers may be helpful for diﬀerential 
diagnosis in such cases.  Dunne et al.  have reported 
that immunohistochemistry may be helpful in distin-
guishing metaplastic carcinoma from others because 
the expression of cytokeratins; 34βE12,  cytokeratin 
5,  and cytokeratin 14 in the sarcomatous area is 
unique for metaplastic carcinomas [3].  According to 
their report,  11 out of 18 cases (61ｵ) were positive 
for 34βE12 in metaplastic carcinomas,  while none of 
the phyllodes tumors was positive.  In contrast,  CD34 
and bcl-2 are more frequently expressed in phyllodes 
tumors than in metaplastic carcinomas; 18 out of 26 
phyllodes tumors (69ｵ) were positive for CD34,  
while none of the metaplastic cancers expressed CD34 
in their stromal area.  Because both 34βE12 and 
CD34 were negative in our case,  the immunohis-
tochemical examination did not support or contradict 
the pathological diagnosis.
　 The coexistence of carcinomatous and heteroge-
neous sarcomatous components is a characteristic of 
metaplastic carcinomas.  Genetic evidence for p53 
alterations,  which is identical in both carcinomatous 
and sarcomatous components,  supports a monoclonal 
histogenesis of various components of the metaplastic 
carcinomas [8,  9].  In contrast,  allelic imbalance is 
not always identical in the stroma and epithelium in 
phyllodes tumors [10].  These molecular examinations 
may therefore help with the diﬀerential diagnosis of 
these diseases.
　 The overall survival rates of metaplastic breast 
cancer have been reported to be the same as those of 
ordinary invasive ductal breast cancers [11].  
Howerver,  Rayson et al.  have reported that disease-
free survival and overall survival is decreased com-
pared to typical carcinoma and that systemic therapy 
appears to be less eﬀective [12].  Some reports have 
recommended that surgical and adjuvant treatment 
should be followed according to the guidelines for 
other common breast cancers [13].
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